A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors
Clinical trial NCT02718911 · COMPLETED
Trial details
- NCT number
- NCT02718911
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-16
- Primary completion
- 2018-12-14
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.